First Hospital of Jilin University

Changchun, Jilin 130028

2 studies enrolling now · 6 studies all time

What they study most

Age Related Macular Degeneration, Breast Cancer, C-Met Exon 14 Mutation, Cervical Cancer, Endometrial Carcinoma, Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Prior History of Squamous Cell Dysplasia and /or Neoplasia, Small-Cell Lung Cancer

Studies at this site

• A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors — Recruiting now
• Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer — Recruiting now
• Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) — Running, not enrolling
• Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy — Completed
• A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD — Completed
• High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia — Status unconfirmed